We are delighted to extend a warm welcome to Hege Tjørsvaag Brattebø as the newest member of the board at Adjutec! We look forward to Hege's valuable contributions as we continue to drive #innovation and success at Adjutec 🌟#WelcomeToTheTeam #BoardMember

Exciting news alert! 🎉 AdjuTec has just completed a capital raise of NOK 16 million to support the phase 1 program of APC148, expected to start in 2024. Get more deatils on our website! adjutecpharma.com/news/tpost/ptu…

In just a few days, our CEO, Bjørn Klem, will join the #AMRconference. Together with leaders from big pharma, academia, investors, and public institutions, we'll address #antimicrobial innovation challenges. Stay tuned for updates!

Thrilled by the insights gained at the 8th AMR Conference! Collaboration is key in tackling antimicrobial resistance (#AMR). Huge thanks to all who contributed! Let's keep pushing forward together! 🌍🔬#antibiotics #GlobalHealth #antimicrobial #Pharmaceutical

Our CSO, Pål Rongved, will be at The Nordic AMR Centre Conference 2024! 🚀 Join researchers, PhDs, and postdocs from Nordic AMR Centers for insightful lectures, engaging posters, and invaluable networking. Don't miss out on connecting with experts! 🤝🌐 #AMR #antibiotics

Join us for an informative podcast featuring our CEO, Bjørn Klem, as he discusses the urgent issue of #antibioticresistance on a global scale and the role AdjuTec is playing to tackle this issue. soundcloud.com/user-972208711… #amr #antibiotics #podcast #PharmaceuticalsBiotech

We're thrilled to be at ECCMID 2024! 🌍 Join us April 27-30 in Barcelona for one of the biggest congresses in infection. AdjuTec looks forward to contributing to the scientific program curated by the ECCMID Programme Committee. See you there! 👋 #AMR #antibiotics

Happy Birthday to our CEO Bjørn Klem! 🎉 Our team wishes you a day full of joy and celebration. Thanks for your inspiring leadership. Here's to a year of success and new opportunities! #HappyBirthday #Leadership

In just a few days, our Chief Clinical & Regulatory Officer, Bjørg Bolstad, will be representing AdjuTec at Uppsala Antibiotic Days 2024 in Sweden! 🌟We look forward to connecting with fellow innovators and experts! #amr #antibiotic #antimicrobialresistance #innovation #UADays24

🎉 Exciting Announcement! 🎉 We're thrilled to welcome Espen Franzon Amundsen to AdjuTec's board! Espen, now at Kistefos AS, has a strong background in investment banking and a Master’s in Finance from the Norwegian School of Economics. Welcome, Espen! 🚀#NewBoardMember #amr

AdjuTec attended the Uppsala Antibiotic Days🦠🔬 Fascinating keynotes on antibiotic resistance! Big thanks to the organizers. Excited to apply our new insights and keep the conversation going. 🙌 #AntibioticResistance #UppsalaAntibioticDays #Healthcare #Innovation #UADays24

🌟 Exciting Times at AdjuTec! 🌟 Our Chief Clinical & Regulatory Officer Bjorg Bolstad just returned from Antibiotic Days in Uppsala and is heading to the UK for the Inward AMR Innovation Mission 2024! Stay tuned for updates as we lead the fight against #AMR! 🚀💊🌍 #amr24

AdjuTec Pharma is featured in a recent Teknisk Ukeblad article, highlighting our work against antibiotic resistance. We are proud to be part of Norway's vibrant health sector and grateful for Innovasjon Norge's support 🌍💊tu.no/brandstory/inn… #amr #antibiotics

AdjuTec presented our lead project to a European panel yesterday, seeking further funding for the phase 1-2 program. Many thanks to Innovasjon Norge and Ixion (part of Shaw Trust) for their invaluable pitch training. It's a significant achievement to have reached the final! 🎉👏 #amr

Happy birthday! 🎉🎂 Today, our incredible CSO, Pål Rongved, is celebrating his special day. Wishing you a fantastic day filled with joy and happiness! #TeamAppreciation #Norway

🌞 After a restful summer, we're diving back into innovation! 💡 Our CEO is heading to Malmö for #NLSDays, the largest Nordic life science partnering event. Excited to connect with leaders & explore the latest trends shaping science & business. See you there! 🤝🧬

🚀 Big milestone! AdjuTec Pharma has started the first-in-human trial for APC148, a breakthrough in the fight against antibiotic resistance. 🦠 This trial could be game-changing for severe infections. Learn more about our progress 👇 adjutecpharma.com/news/tpost/2ca… #amr

📢 Exciting News from AdjuTec Pharma! Jethro Holter joins as our new CEO, bringing 20+ years of life sciences expertise to lead APC148 through clinical trials. Former CEO Bjørn Klem transitions to COO, focusing on R&D.🌟 Read more on our website!

🚀 AdjuTec Pharma is heading to the 9th AMR Conference in Basel on Feb 25-26! Excited to connect 🤝, share insights 💡, and explore collaborations to fight antimicrobial resistance 🦠. Let’s meet up! More info 👉 amr-conference.com

Our CCRO, Bjørg Bolstad, will attend #ESCMIDGlobal2025 in Vienna! Come see our poster📜: "Safety and pharmacokinetics of single ascending doses of APC148, a zinc-chelating MBL-inhibitor, in healthy volunteers." Let’s connect🤝and share insights! 🧫🦠🏥 #amr #antibiotics